A B S T R A C T This study was designed to elucidate the mechanism of elevation of plasma cyclic AMP in uremic man. Plasma cyclic AMP was measured in 15 normal subjects and in 18 patients with severe renal failure. In some members from both groups the kinetic parameters of the metabolism of extracellular cyclic AMP were measured.
INTRODUCTION
Previous studies have shown plasma levels of cyclic AMP (adenosine 3',5'-monophosphate) to be abnormally high in anephric man (1) , and urinary excretion of the cyclic nucleotide has been observed to be decreased in patients with azotemia (2) . Broadus 15 -20% of its total disposal in normal man (3) .
From this it was inferred that the absence of urinary excretion could not explain the magnitude of the increase in plasma cyclic AMP levels in anephric man. In the present study we have attempted to ascertain whether the increased plasma cyclic AMP found in uremia is due to increased cyclic AMP formation, de Table I .
Plasma levels of cyclic AMP in patients with renal failure were more than twice as high as in control subjects. Plasma levels in control subjects were similar to published values (3, 16) . The elevated cyclic AMP levels were independent of the presence or absence of the kidneys or of parathyroid glands (Fig. 1) The effect of successful renal transplantation on the plasma level of cyclic AMP was evaluated in one patient. The plasma cyclic AMP was 67 nM after the bilateral nephrectomy, and it fell to 32 nM 2 wk after the transplantation and rose to 47 during an episode of graft rejection.
Effect of hemodialysis on cyclic AMP. 16 of the 18 subjects with renal failure in the present study were undergoing hemodialysis several times a week for 6-8 h with the Kiil dialyzer. Plasma levels in the two pa- tients not yet having been subjected to dialysis were similar to those of the chronically dialyzed patients. Samples of peripheral blood were drawn from four different patients immediately at the beginning and again at the end of the dialysis sessions; cyclic AMP levels in these samples from the systemic circulation declined only slightly, from a mean of 59.0±7.8 to 51.7+6.0 nM.
The efficacy of hemodialysis on cyclic AMP was studied by simultaneous sampling from arterial and venous lines of the dialyzer as described in Methods. Over the range of blood flow used (120-200 ml/min), clearances of BUN, creatinine, and cyclic AMP were dependent on the blood flow passing through the dialyzer (the correlation coefficient was highly significant, r = 0.92, 0.93, and 0.97, respectively). It appears (Table II) that the clearance rates of the substances were inversely related to their molecular weights.
Kinetic studies of cyclic AMP. Fig. 2 2) . This permits the conclusion that the plasma clearance rate was significantly lower in uremic patients (P < 0.001) (Table III) . In addition, the production rate of plasma cyclic AMP in uremic patients was computed to be significantly higher (P < 0.001); thus, their high plasma levels could not be accounted for on the basis of decreased plasma clearance only. The two independent measurements-plasma clearance rate (estimated from dpm of [$H]cyclic AMP) and the concentration of endogenous cyclic AMP (measured by protein binding)-showed a highly significant negative correlation (r= -0.92, P <0.01).
Finally, the reversible part of the tracer flux between the compartments was calculated (3, 6) . The advantage of this calculation is that it is independent of assumptions about the number and nature of the pools exchanging with the circulating compound (6) . It appears that the percentage of reversible tracer flux is significantly increased in uremia (P < 0.05) (Table III) .
The plasma levels of cyclic AMP in three of the four uremic subjects included in the kinetic studies were coincidentally above the mean level of all patients.
However, the results of the kinetic studies were similar in these three and the fourth subject, R. G., whose level of plasma cyclic AMP was slightly below the mean of the entire group of patients.
DISCUSSION
Chronic renal failure is accompanied by a wide spectrum of disturbances in the transport (17, 18) and metabolism of many substances including several hormones (19) (20) (21) (22) (23) (24) (25) (26) . Impaired renal function has been shown to result in abnormal metabolism of hormones not only via decreased glomerular filtration but also via decreased destruction of the substance by renal parenchyma (22) (23) (24) (25) (26) Broadus et al. demonstrated that urinary excretion in normal man accounts for only about 15-20% of total cyclic AMP disposal (3). Thus, the complete absence of urine formation alone would increase the plasma level only from about 22 to 27 nM in the new steady state.2 In the present study, the plasma clearance of cyclic AMP was, on the average, 270 ml/min less in uremic patients than in normal subj ects, a difference that is not fully accounted for by the mere lack of normal glomerular filtration. It is concluded on this basis that the metabolic clearance of cyclic AMP in uremia is decreased. Although Schneider and Jutzler (27) have reported that the elevated plasma levels of cyclic AMP in uremia were correlated with the reduction in glomerular filtration rate, a number of other observations 2In the steady state, total disposal rate = concentration of cyclic AMP X plasma clearance=plasma production rate; i.e., concentration of cyclic AMP =plasma production rate X (metabolic clearance +kidney clearance) '. By substituting 0.120 liter/min for kidney clearance (3) and using other normal values from Table III , it can be seen that if metabolic clearance and production were unchanged, the absence of kidney clearance would result in a concentration of cyclic AMP equal to: 13.6 X (0.624 -0.120)-1= 27 nM. support the finding of the present study that a reduction in glomerular filtration rate cannot entirely account for the degree of elevation of plasma cyclic AMP. Recently, Wehmann, Blonde, and Steiner (28, 29) , using infusions of tritiated cyclic nucleotides in dogs, observed that urinary excretion accounted for only about two-thirds of the total kidney clearance of cyclic AMP, extraction of the nucleotide by renal parenchymal tissue apparently accounting for the remainder. A significant role of renal extraction, in contrast to excretion, was also demonstrated by the experiments of Coulson, RochRamel, and Bowman, who studied the disappearance of ['H]cyclic AMP from plasma before and after nephrectomy in rats (30) and by those of Coulson and Bowman (31), who studied the handling of extracellular cyclic AMP by the perfused rat kidney. The extraction of cyclic AMP by kidney parenchyma appears to be dependent upon a transport system that can be blocked by probenicid (30, 31) . Thus, the kidney appears to participate in the metabolic clearance of plasma cyclic AMP in addition to the urinary excretion of the nucleotide.
Cyclic AMP in Uremia
Furthermore, even the decrease in the plasma clearance of cyclic AMP does not entirely explain the elevated plasma level of the nucleotide in uremia. An increase in production rate appears to be another contributing factor (Table III) . The increase of the "plasma production rate" could be secondary to increased activity of adenylate cyclase (conceivable because of increased levels of several hormones) and/or to decreased activity of phosphodiesterase. Alternatively, the increased "plasma production rate" and decreased metabolic clearance could be related to abnormal transport of cyclic AMP between compartments, since an increased percentage of "reversible flux" of extracellular cyclic AMP was found in uremic patients (Table III) . At present, it is not possible to identify the anatomical "compartments" involved in the flux of cyclic AMP into and out of the plasma. Theoretically, if metabolic clearance of plasma cyclic AMP involves saturable processes, an increased production rate could contribute to a reduced metabolic clearance rate by elevating plasma cyclic AMP to near-saturating concentrations.
Several abnormalities in uremia including decreased platelet adhesiveness and abnormal sodium transport have been attributed to the presence of unidentified "toxins" in plasma (32) (33) (34) . Whether or not such factors might influence the metabolism of cyclic AMP is unknown. Interestingly, cyclic AMP itself has been reported to be involved in the physiological regulation of both platelet adhesiveness (35, 36) and sodium transport (37) (38) (39) . Although this study has not delineated a role for cyclic AMP in the pathophysiology of any abnormalities in uremia, the fact that the metabolism of extracellular cyclic AMP is abnormal in uremia should encourage studies of the nucleotide's intracellular metabolism and possible involvement in other pathological aspects of this disease.
Note added in proof. We have recently also measured cyclic GMP in uremic and control subjects included in this present study. Cyclic GMP levels were 4.2±SEM 0.7 nM (n=9) in control subjects and 19.5±2.9 nM (n= 5) in uremics. A single passage of blood through a dialyzing machine decreased cyclic GMP levels in uremics to 12.9±1.2 nM.
